All lobbying filings
BROWNSTEIN HYATT FARBER SCHRECK, LLP
Lobbying for ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS · Pharmaceutical company
Filing
Registration
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 17, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
District of Columbia
Lobbyists on this filing
4
-
ADAM STEINMETZ New on this filingPreviously held: Policy Advisor - Committee on the Budget, United States House of Representatives
-
HAROLD HANCOCK New on this filingPreviously held: Tax Counsel, House Ways and Means Committee
-
JOSEPH BRADY HOWELL Former member of Congress New on this filingPreviously held: Treas., Leg. Aff., Sr Adv.; H. For. Aff. Comm., Rep Royce, Asst. Staff Dir., Pol. An., Spec. Asst.; H. Admin. Comm., Rep Miller, Int.; H. For. Aff. Comm., Eur./Eurasia Sub., Rep Burton, Prof. Staff, Rep./Policy Adv., Assoc., Rep.; Rep Burton, Int.
-
EMILY FELDER New on this filingPreviously held: Director of the Office of Legislation, CMS; Counsel, House Energy and Commerce Committee; Counsel, Senate Committee on Homeland Security and Government Affairs; Counsel, House Oversight and Government Reform Committee
Lobbying activity
3
Issues related to pharmaceutical manufacturing, tax and trade policy affecting the pharmaceutical industry, and the companys expansion of its domestic footprint.
Issues related to pharmaceutical manufacturing, tax and trade policy affecting the pharmaceutical industry, and the companys expansion of its domestic footprint.
Issues related to pharmaceutical manufacturing, tax and trade policy affecting the pharmaceutical industry, and the companys expansion of its domestic footprint.
Foreign interests disclosed
2
-
MALLINCKRODT INTERNATIONAL FINANCE SALuxembourg · Luxembourg · owns 100% of the client · contributed $0.00
-
MALLINCKRODT PLCIreland · Blanchardstown, Dublin · owns 100% of the client · contributed $0.00